FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079783845> ?p ?o ?g. }

• W2079783845 endingPage "58" @default.
• W2079783845 startingPage "53" @default.
• W2079783845 abstract "This trial investigated the efficacy of a combination of high-dose interferon-alpha (IFN-alpha) with ribavirin in IFN nonresponders.304 patients with chronic hepatitis C were treated with 5 MU IFN-alpha2b (IntronA(R), Schering-Plough) per TIW for 3 months. Nonresponders (defined by HCV-RNA positivity in serum after the 3 months of therapy) were randomized either to continue with IFN (5 MU IFN per TIW followed by 10 MU per TIW for each 3 months) alone (group A) or in combination with ribavirin (1-1.2 g per day) (group B). ALT was measured in monthly intervals, HCV-RNA in 3 monthly intervals. Pretreatment characteristics of the randomized patients were as follows: group A, n = 76; m/f, 54/22; 16% cirrhosis, age, 45. 7 +/- 12 years; ALT (U per litre), 66 +/- 35; group B, n = 81; m/f, 57/24; 17% cirrhosis, age, 48.2 +/- 12; ALT, 71 +/- 40. After 9 months of treatment, nine (11.6%) and 27 (32.5%, P = 0.0066) patients were HCV-RNA negative and 51 and 39 were HCV-RNA positive, in groups A and B, respectively. There were 17 drop-outs in group A and 15 in group B. Six months after treatment only two patients in group A (2.5%) and five (6%, P = 0.06) in group B had normal ALT and no detectable HCV-RNA in serum. In addition to the well-known side-effects of IFN the mean haemoglobin concentration dropped by 2 g per litre in group B. These data indicate that a combination of high-dose IFN with ribavirin is effective in inducing a short-lasting complete response in one-third of IFN nonresponders. Prolonged treatment with IFN/ribavirin may be necessary to obtain a sustained response." @default.
• W2079783845 created "2016-06-24" @default.
• W2079783845 creator A5008349108 @default.
• W2079783845 creator A5013541190 @default.
• W2079783845 creator A5026730867 @default.
• W2079783845 creator A5046270363 @default.
• W2079783845 creator A5048297844 @default.
• W2079783845 creator A5056386043 @default.
• W2079783845 creator A5061474122 @default.
• W2079783845 creator A5068631395 @default.
• W2079783845 creator A5071341706 @default.
• W2079783845 creator A5071850752 @default.
• W2079783845 creator A5073197069 @default.
• W2079783845 date "1999-07-01" @default.
• W2079783845 modified "2023-10-18" @default.
• W2079783845 title "Interim analysis of a randomized controlled trial of combination of ribavirin and high dose interferon‐α in interferon nonresponders with chronic hepatitis C" @default.
• W2079783845 cites W111928671 @default.
• W2079783845 cites W1975662144 @default.
• W2079783845 cites W1981095040 @default.
• W2079783845 cites W1982302584 @default.
• W2079783845 cites W1985440692 @default.
• W2079783845 cites W1993262285 @default.
• W2079783845 cites W1996562542 @default.
• W2079783845 cites W2025062645 @default.
• W2079783845 cites W2032552170 @default.
• W2079783845 cites W2043144554 @default.
• W2079783845 cites W2059596847 @default.
• W2079783845 cites W2071402530 @default.
• W2079783845 cites W2074416637 @default.
• W2079783845 cites W2076682837 @default.
• W2079783845 cites W2079002457 @default.
• W2079783845 cites W2079771726 @default.
• W2079783845 cites W2082463095 @default.
• W2079783845 cites W2094107346 @default.
• W2079783845 cites W2119600310 @default.
• W2079783845 cites W2129767605 @default.
• W2079783845 cites W2155541504 @default.
• W2079783845 cites W2158694627 @default.
• W2079783845 cites W2328129693 @default.
• W2079783845 cites W2335968781 @default.
• W2079783845 cites W2336799715 @default.
• W2079783845 doi "https://doi.org/10.1046/j.1365-2893.1999.00005.x" @default.
• W2079783845 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10760037" @default.
• W2079783845 hasPublicationYear "1999" @default.
• W2079783845 type Work @default.
• W2079783845 sameAs 2079783845 @default.
• W2079783845 citedByCount "16" @default.
• W2079783845 countsByYear W20797838452013 @default.
• W2079783845 crossrefType "journal-article" @default.
• W2079783845 hasAuthorship W2079783845A5008349108 @default.
• W2079783845 hasAuthorship W2079783845A5013541190 @default.
• W2079783845 hasAuthorship W2079783845A5026730867 @default.
• W2079783845 hasAuthorship W2079783845A5046270363 @default.
• W2079783845 hasAuthorship W2079783845A5048297844 @default.
• W2079783845 hasAuthorship W2079783845A5056386043 @default.
• W2079783845 hasAuthorship W2079783845A5061474122 @default.
• W2079783845 hasAuthorship W2079783845A5068631395 @default.
• W2079783845 hasAuthorship W2079783845A5071341706 @default.
• W2079783845 hasAuthorship W2079783845A5071850752 @default.
• W2079783845 hasAuthorship W2079783845A5073197069 @default.
• W2079783845 hasConcept C126322002 @default.
• W2079783845 hasConcept C168563851 @default.
• W2079783845 hasConcept C176674119 @default.
• W2079783845 hasConcept C203014093 @default.
• W2079783845 hasConcept C2522874641 @default.
• W2079783845 hasConcept C2776178377 @default.
• W2079783845 hasConcept C2777214474 @default.
• W2079783845 hasConcept C2777785397 @default.
• W2079783845 hasConcept C2780040827 @default.
• W2079783845 hasConcept C2909179924 @default.
• W2079783845 hasConcept C3020491458 @default.
• W2079783845 hasConcept C61943457 @default.
• W2079783845 hasConcept C71924100 @default.
• W2079783845 hasConcept C90924648 @default.
• W2079783845 hasConceptScore W2079783845C126322002 @default.
• W2079783845 hasConceptScore W2079783845C168563851 @default.
• W2079783845 hasConceptScore W2079783845C176674119 @default.
• W2079783845 hasConceptScore W2079783845C203014093 @default.
• W2079783845 hasConceptScore W2079783845C2522874641 @default.
• W2079783845 hasConceptScore W2079783845C2776178377 @default.
• W2079783845 hasConceptScore W2079783845C2777214474 @default.
• W2079783845 hasConceptScore W2079783845C2777785397 @default.
• W2079783845 hasConceptScore W2079783845C2780040827 @default.
• W2079783845 hasConceptScore W2079783845C2909179924 @default.
• W2079783845 hasConceptScore W2079783845C3020491458 @default.
• W2079783845 hasConceptScore W2079783845C61943457 @default.
• W2079783845 hasConceptScore W2079783845C71924100 @default.
• W2079783845 hasConceptScore W2079783845C90924648 @default.
• W2079783845 hasIssue "s1" @default.
• W2079783845 hasLocation W20797838451 @default.
• W2079783845 hasLocation W20797838452 @default.
• W2079783845 hasOpenAccess W2079783845 @default.
• W2079783845 hasPrimaryLocation W20797838451 @default.
• W2079783845 hasRelatedWork W197269132 @default.
• W2079783845 hasRelatedWork W1975710210 @default.
• W2079783845 hasRelatedWork W2059589513 @default.
• W2079783845 hasRelatedWork W2079783845 @default.
• W2079783845 hasRelatedWork W2088431399 @default.

• next